Case 11 — Joint Comfort: Exosome Intra-Articular Program

Program design

The joint-comfort program delivers exosome preparation by intra-articular injection for clients with early-to-mid stage osteoarthritis, sports-related meniscus injury, or age-related joint degeneration. The preparation runs on the same closed micro-batch line with full COA documentation.

Mechanism (published literature)

Exosomes support chondrocyte proliferation and repair, reduce inflammatory response, provide antioxidant protection to joint structures, and promote angiogenesis. A registered study (ChiCTR2200059351) supports the safety profile of this approach.

Observed context

Clients with grade-III meniscus injury received local injection as part of a documented program. Recovery tracking was maintained by the network clinic through their standard intake forms.

Compliance frame

The program operates within wellness/cosmetic scope for consumer delivery, with clinical documentation available for professional channels. Full-panel COA and cold-chain hand-off records accompany each batch.

Observational records from internal application programs, anonymized. Individual results vary. These notes describe program design contexts and are not medical advice, nor a promise of outcomes.